Investigation of Rocaltrol prescribed before parathyroidectomy surgery to assess the effect of hypocalcemia after surgery in patients with parathyroid edenoma
Phase 3
- Conditions
- Primary hyperparathyroidismInvestigation of Rocaltrol prescribed before parathyroidectomy surgery to assess the effect of hypocalcemia after surgery in patients with parathyroid edenoma.E21.0
- Registration Number
- IRCT20220822055773N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Primary hyperparathyroidism patients operated in the surgery department of Shariati Hospital
Exclusion Criteria
Patients who have hyperparathyroid crisis before the operation and those who are going to remove all 4 parathyroid glands (patients with MEN) are excluded from the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The use of oral rocartrol before surgery to reduce hypocalcemic symptoms and reduce the need for hospitalization in primary hyperparathyroidism patients. Timepoint: PTH measurement during surgery and before incision and 10 minutes after adenoma removal - serum calcium measurement every 6 hours after surgery. Method of measurement: Demographic information is obtained by interviewing the patient. From the results of the laboratory, data related to the measurement of calcium, PTH, Vit D, Alk.p, through ultrasound or scanning of the adenoma site and through clinical examination of hypocalcemic symptoms are extracted.
- Secondary Outcome Measures
Name Time Method PTH measurement during surgery and before incision and 10 minutes after adenoma removal - serum calcium measurement every 6 hours after surgery. Timepoint: PTH measurement during surgery and before incision and 10 minutes after adenoma removal - serum calcium measurement every 6 hours after surgery. Method of measurement: Demographic information is obtained by interviewing the patient. From the results of the laboratory, data related to the measurement of calcium, PTH, Vit D, Alk.p, through ultrasound or scanning of the adenoma site and through clinical examination of hypocalcemic symptoms are extracted.